AAAAAA

   
Results: 1-22 |
Results: 22
2ND NEOPLASMS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS - A REPORT OF 6 CASES IN A COHORT OF 171 PATIENTS FROM A SINGLE INSTITUTION
Authors: ODDOU S VEY N VIENS P BARDOU VJ FAUCHER C STOPPA AM CHABANNON C CAMERLO J BOUABDALLAH R GASTAUT JA MARANINCHI D BLAISE D
Citation: S. Oddou et al., 2ND NEOPLASMS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS - A REPORT OF 6 CASES IN A COHORT OF 171 PATIENTS FROM A SINGLE INSTITUTION, Leukemia & lymphoma, 31(1-2), 1998, pp. 187-194
OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD)
Authors: CHABANNON C AURRAN T VIRET F FAUCHER C STOPPA AM LADAIQUE P VEY N BOUABDALLAH R NOVAKOVITCH G GASTAUT JA MARANINCHI D BLAISE D
Citation: C. Chabannon et al., OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD), Experimental hematology, 26(8), 1998, pp. 364-364
EFFECTIVE T-CELL DEPLETION OF ALLOGENEIC BLOOD AND MARROW GRAFTS, USING A CD34+ CELL SELECTION DEVICE
Authors: VIRET F CHABANNON C VEY N STOPPA AM FAUCHER C NOVAKOVITCH G OZIELTAIEB S GASTAUT JA MARANINCHI D BLAISE D
Citation: F. Viret et al., EFFECTIVE T-CELL DEPLETION OF ALLOGENEIC BLOOD AND MARROW GRAFTS, USING A CD34+ CELL SELECTION DEVICE, Bone marrow transplantation, 21, 1998, pp. 102-102
IMMUNE RECOVERY AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION - A COMPARATIVE-STUDY OF 78 PATIENTS
Authors: CHARBONNIER A SAINTY D ARNOULET C FAUCHER C VIRET F VEY N STOPPA AM CHABANNON C MARANINCHI D BLAISE D
Citation: A. Charbonnier et al., IMMUNE RECOVERY AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION - A COMPARATIVE-STUDY OF 78 PATIENTS, Bone marrow transplantation, 21, 1998, pp. 103-103
EARLY AND PROLONGED (D1-86) ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Authors: STOPPE AM VEY N VIRET F FAUCHET C CHABANNON C CAMERLO J CAPPIELLO M BLAISE D MARANINCHI D
Citation: Am. Stoppe et al., EARLY AND PROLONGED (D1-86) ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 363-363
OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD)
Authors: CHABANNON C AURRANSCHLEINITZ T VIRET F FAUCHER C STOPPA AM LADAIQUE R VEY N BOUABDALLAH R NOVAKOVITCH G GASTAUT JA MARANINCHI D BLAISE D
Citation: C. Chabannon et al., OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD), British Journal of Haematology, 102(1), 1998, pp. 319-319
CLINICAL AND BIOLOGICAL EFFECTS OF GAMMA-INTERFERON AND THE COMBINATION OF GAMMA-INTERFERON AND INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: VEY N VIENS P FOSSAT C OLIVE D SAINTY D BAUME D STOPPA AM BOUABDALLAH R BRANDELY M GASTAUT JA MARANINCHI D BLAISE D
Citation: N. Vey et al., CLINICAL AND BIOLOGICAL EFFECTS OF GAMMA-INTERFERON AND THE COMBINATION OF GAMMA-INTERFERON AND INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, European cytokine network, 8(4), 1997, pp. 389-394
INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA
Authors: STOPPA AM BOUABDALLAH R CHABANNON C NOVAKOVITCH G VEY N CAMERLO J BLAISE D XERRI L RESBEUT M DISTEFANO D BARDOU VJ GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 15(5), 1997, pp. 1722-1729
INTENSIVE SEQUENTIAL CHEMOTHERAPY (ISC92-95) AND REPEATED PERIPHERAL-BLOOD STEM-CELL (PBSC) IN POOR-RISK UNTREATED NON-HODKIN-LYMPHOMA (NHL)
Authors: STOPPA AM BOUABDALLAH R CHABANNON C VEY N ROSSI JF BOULAT O COSTELLO R CAMERLO J NOVAKOVITCH G BARDOU VJ BLAISE D GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY (ISC92-95) AND REPEATED PERIPHERAL-BLOOD STEM-CELL (PBSC) IN POOR-RISK UNTREATED NON-HODKIN-LYMPHOMA (NHL), Experimental hematology, 25(8), 1997, pp. 410-410
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 - RESULTS OF A PHASE-II STUDY IN 21 PATIENTS
Authors: VEY N BLAISE D OLIVE D LAFAGE M VIENS P BAUME D CAMERLO J STOPPA AM GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: N. Vey et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 - RESULTS OF A PHASE-II STUDY IN 21 PATIENTS, Experimental hematology, 25(8), 1997, pp. 481-481
EVALUATION OF AN AMBULATORY CHEMOTHERAPY REGIME PRIOR TO AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: VEY N STOPPA AM FAUCHER C CHABANNON C BOUABDALLAH R COSTELLO R CAMERLO J LAFAGE M SAINTY M GASTAUT JA MARANINCHI D BLAISE D
Citation: N. Vey et al., EVALUATION OF AN AMBULATORY CHEMOTHERAPY REGIME PRIOR TO AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR CHRONIC MYELOGENOUS LEUKEMIA, Experimental hematology, 25(8), 1997, pp. 482-482
A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN MALIGNANT-LYMPHOMAS
Authors: VEY N BLAISE D TIBERGHIEN P ATTAL M PICO JL REIFFERS J HARROUSSEAU JL FIERE D TABILIO A GABUS R BRANDELY M MARANINCHI D
Citation: N. Vey et al., A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN MALIGNANT-LYMPHOMAS, Leukemia & lymphoma, 21(1-2), 1996, pp. 107-114
A PILOT-STUDY OF GAMMA-INTERFERON WITH OR WITHOUT INTERLEUKIN-2 AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK MALIGNANCIES
Authors: VEY N MARANINCHI D OLIVE D FOSSAT C BAUME D SAINTY D STOPPA AM VIENS P BRANDELY M BLAISE D
Citation: N. Vey et al., A PILOT-STUDY OF GAMMA-INTERFERON WITH OR WITHOUT INTERLEUKIN-2 AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK MALIGNANCIES, Experimental hematology, 24(9), 1996, pp. 369-369
INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED PERIPHERAL-BLOOD CELLSUPPORT FOR UNTREATED POOR-PROGNOSIS LYMPHOMAS
Authors: STOPPA AM BOUABDALLAH R CHABANNON C NOVAKOVITCH G VEY N BOULET JM CAMERLO J FORTANIER C BLAISE D GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED PERIPHERAL-BLOOD CELLSUPPORT FOR UNTREATED POOR-PROGNOSIS LYMPHOMAS, Experimental hematology, 24(9), 1996, pp. 699-699
A PILOT-STUDY OF BUSULFAN AND MELPHALAN AS PREPARATORY REGIMEN PRIOR TO ALLOGENEIC BONE-MARROW TRANSPLANTATION IN REFRACTORY OR RELAPSED HEMATOLOGICAL MALIGNANCIES
Authors: VEY N DEPRIJCK B FAUCHER C STOPPA AM SAINTY D LAFAGE M BOUABDALLAH R CHABANNON C CAMERLO J GASTAUT JA MARANINCHI D BLAISE D
Citation: N. Vey et al., A PILOT-STUDY OF BUSULFAN AND MELPHALAN AS PREPARATORY REGIMEN PRIOR TO ALLOGENEIC BONE-MARROW TRANSPLANTATION IN REFRACTORY OR RELAPSED HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 18(3), 1996, pp. 495-499
CORRECTION OF APLASTIC-ANEMIA COMPLICATING PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - ABSENCE OF ERADICATION OF THE PNH CLONE AND DEPENDENCE OF RESPONSE ON CYCLOSPORINE-A ADMINISTRATION
Authors: STOPPA AM VEY N SAINTY D ARNOULET C CAMERLO J CAPPIELLO MA GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., CORRECTION OF APLASTIC-ANEMIA COMPLICATING PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - ABSENCE OF ERADICATION OF THE PNH CLONE AND DEPENDENCE OF RESPONSE ON CYCLOSPORINE-A ADMINISTRATION, British Journal of Haematology, 93(1), 1996, pp. 42-44
RECOMBINANT INTERLEUKIN-2 (RIL-2) INDUCES CYTOGENETIC RESPONSES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) IN CHRONIC PHASE
Authors: VEY N BAUME D LAFAGE M GABUS R OLIVE D CAMERLO J STOPPA AM BOUABDALLAH R GASTAUT JA MARANINCHI D BLAISE D
Citation: N. Vey et al., RECOMBINANT INTERLEUKIN-2 (RIL-2) INDUCES CYTOGENETIC RESPONSES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) IN CHRONIC PHASE, Blood, 88(10), 1996, pp. 3536-3536
INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS LYMPHOMAS
Authors: STOPPA AM BOUABDALLAH R CHABANNON C NOVAKOVITCH G VEY N BOULET JM CAMERLO J FORTANIE C BLAISE D GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS LYMPHOMAS, Blood, 86(10), 1995, pp. 830-830
A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN 25 MALIGNANT-LYMPHOMAS
Authors: VEY N BLAISE D TIBERGHIEN P ATTAL M PICO JL REIFFERS J HARROUSSEAU JL FIERE D TABILIO A GABUS R BRANDELY M STOPPA AM MARANINCHI D
Citation: N. Vey et al., A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN 25 MALIGNANT-LYMPHOMAS, Blood, 86(10), 1995, pp. 3874-3874
DELAYED ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION - EFFECT AN GRANULOCYTE RECOVERY
Authors: VEY N MOLNAR S FAUCHER C LECORROLLER AG STOPPA AM VIENS P BOUABDALLAH R CAMERLO J NOVAKOVITCH G MANNONI P GASTAUT JA MOATTI JP MARANINCHI D BLAISE D
Citation: N. Vey et al., DELAYED ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION - EFFECT AN GRANULOCYTE RECOVERY, Bone marrow transplantation, 14(5), 1994, pp. 779-782
BONE-MARROW TRANSPLANTATION IN 63 ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: VEY N BLAISE D STOPPA AM BOUABDALLAH R LAFAGE M SAINTY D COWEN D VIENS P LEPEU G BLANC AP JAUBERT D GAUD C MANNONI P CAMERLO J RESBEUT M GASTAUT JA MARANINCHI D
Citation: N. Vey et al., BONE-MARROW TRANSPLANTATION IN 63 ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION, Bone marrow transplantation, 14(3), 1994, pp. 383-388
IMMUNOTHERAPY WITH RECOMBINANT IL2 (RIL2) IN THE TREATMENT OF MALIGNANT LYMPHOMAS-(L)
Authors: BLAISE D GISSELBRECHT C VEY N PICO JL TIBERGHIEN P MILPIED N COIFFIER B ATTAL M BOSLY A REIFFERS J TILLY H TABILIO A GABUS R BRANDELY M MARANINCHI D
Citation: D. Blaise et al., IMMUNOTHERAPY WITH RECOMBINANT IL2 (RIL2) IN THE TREATMENT OF MALIGNANT LYMPHOMAS-(L), Journal of cellular biochemistry, 1993, pp. 268-268
Risultati: 1-22 |